What Does Danaher (DHR) FDA Clearance For AI AFib Detection Mean Now?

Danaher (NYSE:DHR) subsidiary Masimo received FDA clearance for AI-enabled atrial fibrillation detection in its Radius VSM wearable monitor. The approved system uses artificial intelligence to identify potential AFib episodes in patients using Masimo’s hospital-grade wireless device. The AFib detection feature is intended for use in acute care settings, adding a new digital monitoring function to Danaher’s diagnostics tools. Masimo’s new AI atrial fibrillation clearance matters, but...